Fundraising Fox

Alung

Acquired

Pittsburgh, US · 3,583 employees on LinkedIn · 4 known investors

LivaNova develops medical devices and therapies aimed at treating conditions such as epilepsy (seizures), sleep disorders, depression, and cardiac conditions. It operates in the medical technology industry, serving patients and healthcare providers.

BiotechHealthtechMedical Devices

Founders & leadership

PM
Peter M. DeComoExecutive
DJ
David J. HaffnerExecutive
NJ
Nicholas J KuhnExecutive

Board

DLDavid L. Motley
David L. MotleyinBoard directorGeneral Partner at Black Tech Nation Ventures
JMJohn McIlwraith
John McIlwraithinBoard directorManaging Director at Allos Ventures
JJ
Joseph J Stevens IIIBoard director
GG
Gary G. GlausserBoard director
KJ
Kraig J. McEwenBoard director
GE
Gerald E. McGinnisBoard director
NE
Nicholas E. CullenBoard director
WB
William B RossBoard director

Investors · 4

Allos VenturesCincinnati · $1M – $6M
Birchmere VenturesPittsburgh · $500K – $5M
Riverfront Ventures, LLCPittsburgh · $250K – $1M
Black Tech Nation VenturesreportedPittsburgh · $250K – $1Mvia David Motley · board

Reported raises · per SEC filings

Form D private placements

$101.3M disclosed across 12 rounds · 2011–2021

▶$4.6MraisedAug 2021 · 55 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Adam G. SeiverDirector
  • Jeanne CunicelliDirector
  • David MotleyDirector
  • Gary G. GlausserDirector
  • Peter M. DeComoExecutive Officer, Director
  • John KuzmishinDirector
  • David J. HaffnerExecutive Officer
Offering amount
$12M
Amount sold
$4.6M
Sales commissions
$12K
Placement agents
Weild & Co.
First sale
May 2021
Incorporated
Corporation, Pennsylvania
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.4MraisedNov 2020 · 47 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeanne CunicelliDirector
  • Adam G. SeiverDirector
  • John KuzmishinDirector
  • Peter M. DeComoExecutive Officer, Director
  • David MotleyDirector
  • Kraig J. McEwenDirector
  • Gary G. GlausserDirector
  • David J. HaffnerExecutive Officer
Offering amount
$15M
Amount sold
$5.4M
First sale
Oct 2020
Incorporated
Corporation, Pennsylvania
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedJun 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Adam G. SeiverDirector
  • Jeanne CunicelliDirector
  • David MotleyDirector
  • Gary G. GlausserDirector
  • Peter M. DeComoExecutive Officer, Director
  • Kraig J. McEwenDirector
  • John KuzmishinDirector
  • David J. HaffnerExecutive Officer
Offering amount
$2M
Amount sold
$2M
First sale
May 2020
Incorporated
Corporation, Pennsylvania
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.3MraisedFeb 2020 · 52 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter M. DeComoExecutive Officer, Director
  • David MotleyDirector
  • Kraig J. McEwenDirector
  • Adam G. SeiverDirector
  • David J. HaffnerExecutive Officer
  • Jeanne CunicelliDirector
  • Gary G. GlausserDirector
Offering amount
$5M
Amount sold
$3.3M
First sale
Jan 2020
Incorporated
Corporation, Pennsylvania
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedFeb 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter M. DeComoExecutive Officer, Director
  • David MotleyDirector
  • Kraig J. McEwenDirector
  • Adam G. SeiverDirector
  • David J. HaffnerExecutive Officer
  • Jeanne CunicelliDirector
  • Gary G. GlausserDirector
Offering amount
$3M
Amount sold
$3M
Sales commissions
$180K
Placement agents
Kee Colen
First sale
Feb 2020
Incorporated
Corporation, Pennsylvania
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedAug 2019 · 48 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John E. McIlwraithDirector
  • Gary G. GlausserDirector
  • Kraig J. McEwenDirector
  • David MotleyDirector
  • Peter M. DeComoExecutive Officer, Director
  • David J HaffnerExecutive Officer
  • Adam SeiverDirector
  • Jeanne CunicelliDirector
Offering amount
$5M
Amount sold
$5M
First sale
Aug 2019
Incorporated
Corporation, Pennsylvania
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedJan 2019 · 61 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeanne CunicelliDirector
  • Kraig J. McEwenDirector
  • Peter M. DeComoExecutive Officer, Director
  • Gerald E. McGinnisDirector
  • Adam SeiverDirector
  • Gary G. GlausserDirector
  • David J. HaffnerExecutive Officer
  • John E. McIlwraithDirector
Offering amount
$5M
Amount sold
$5M
First sale
Dec 2018
Incorporated
Corporation, Pennsylvania
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$37.5MraisedDec 2017 · 96 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David J. HaffnerExecutive Officer
  • John McIlwraithDirector
  • Gary G. GlausserDirector
  • Adam SeiverDirector
  • Jeanne CunicelliDirector
  • Peter M. DeComoExecutive Officer, Director
  • Gerald E. McGinnisDirector
  • Kraig J. McEwenDirector
Offering amount
$42.6M
Amount sold
$37.5M
Sales commissions
$1.5M
Placement agents
Kee Colen
First sale
Mar 2017
Incorporated
Corporation, Pennsylvania
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Alung do?
LivaNova develops medical devices and therapies aimed at treating conditions such as epilepsy (seizures), sleep disorders, depression, and cardiac conditions. It operates in the medical technology industry, serving patients and healthcare providers.
Who are Alung's investors?
Alung's investors include Allos Ventures, Birchmere Ventures, Riverfront Ventures, LLC, Black Tech Nation Ventures.
How much funding has Alung raised?
Alung has disclosed $101.3M raised across 12 rounds.
Where is Alung headquartered?
Alung is headquartered in Pittsburgh, US.